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Background: There have been few reports of long-term follow-up after 
truncus arteriosus repair in infancy. Methods: A retrospective review was 
performed to assess long-term outcomes among 165 patients who survived 
the initial hospital stay after complete repair of truncus arteriosus ince 
1975. The median age at truncus repair over this 20-year experience was 3.5 
months (range 2 days to 36 years), and 81% of patients were less than 1 year 
of age. Previous pulmonary artery banding had been performed in 15 
patients, and two patients had undergone prior repair of interrupted aortic 
arch. Significant procedures performed along with truncus repair included 
truncal valve replacement (n = 10) or repair (n = 5) and repair of interrupted 
aortic arch (n = 4). Results: Patients were followed up for up to 20.4 years 
(median 10.5 years). Twenty.five patients were lost at cross-sectional follow-up, 
with a total of 67 patient-years of follow-up available on these patients. There 
have been 23 late deaths, eight of which occurred within 6 months of repair and 
13 of which occurred within 1 year. Ten of the late deaths were related to 
reoperations. Actuarial survival among all hospital survivors was 90% at 5 
years, 85% at 10 years, and 83% at 15 years and was essentially identical for 
infants alone. A significant independent risk factor for poorer long-term 
survival was truncus with moderate to severe truncal valve insufficiency before 
repair. During the follow-up period, 107 patients underwent 133 conduit 
reoperations. Median time to conduit reoperation was 5.5 years, and the only 
factor significantly associated with shorter time to conduit replacement was 
smaller conduit size at initial repair. In addition, 26 patients underwent 30 
truncal valve replacements. Six patients required truncal valve replacement 
before any conduit-related reintervention, with two associated deaths. 
Actuarial freedom from truncal valve replacement among patients with no 
prerepair truncal valve insufficiency was 95% at 10 years. Actuarial freedom 
from truncal valve replacement was significantly lower among patients with 
truncal insufficiency before initial repair (63% at 10 years). At follow-up, all 
patients except hree were in New York Heart Association functional class 
I. Conclusions: Ten- to 20-year survival and functional status are xcellent 
among infants undergoing complete repair of truncus arteriosus. Conduit 
replacement or revision is almost inevitably necessary in this group of 
patients. (J Thorac Cardiovasc Surg 1997;113:869-79) 
T runcus arteriosus is an uncommon complex car- diovascular malformation that represents ap- 
proximately 2% to 4% of all congenital heart lesions 
in several autopsy series, a' 2 The distinguishing fea- 
tures of truncus arteriosus include a single arterial 
trunk that supplies systemic, coronary, and pulmo- 
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Table I. Associated cardiovascular anomalies in 
patients undergoing complete repair of truncus 
arteriosus 
Patients 
Anomaly No. % 
Truncal valve insufficiency 51 31 
Mild 24 15 
Moderate 19 12 
Severe 8 5 
Patent foramen ovale or secundnm 37 22 
atrial septal defect 
Hypoplastic or stenotic pulmonary 29 18 
arteries 
Bilateral or main pulmonary 16 10 
artery 
Unilateral 13 8 
Right aortic arch 20 12 
DiGeorge syndrome 14 8 
Interrupted aortic arch 6 4 
Persistent left superior vena cava 5 3 
Partial anomalous pulmonary 2 1.2 
venous drainage 
Atrioventricular canal defect 1 0.6 
Aberrant left subclavian artery 1 0.6 
Double-orifice mitral valve 1 0.6 
Hypoplastic tricuspid valve 1 0.6 
nary blood flow and an infundibular ventricular 
septal defect (VSD), both of which are thought to 
result from failure of proper conotruncal septation. 
The natural history of this lesion is such that fewer 
than 25% of all children born with truncus arterio- 
sus will survive beyond the first year of life without 
surgical intervention) 
The first successful surgical correction of truncus 
arteriosus was performed in 1967 by McGoon, Ras- 
telli, and Ongley, 4who used a valved aortic allograft 
to establish right ventricular-pulmonary rtery con- 
tinuity. 4 Over the past three decades, surgical man- 
agement of truncus arteriosus has evolved to include 
earlier repair, first during infancy and now primarily 
in the neonatal period, to avoid the severe morbidity 
produced by progressive pulmonary vascular ob- 
Structive disease. 5-8 However, long-term follow-up 
studies have been limited to older children who 
underwent runcus repair predominantly after pri- 
mary palliative pulmonary banding operations or, 
less frequently, who had congenital stenosis of the 
pulmonary arteries and thus a protected pulmonary 
vascular bed. 9' 10 Few data are available regarding 
long-term survival and freedom from reintervention 
after repair of truncus arteriosus in infancy. The 
purpose of this report was to carefully examine risk 
factors for adverse long-term outcomes after pri- 
mary repair of truncus arteriosus at an institution in 
which a policy of early repair had been adopted and 
applied to a large number of infants. Because many 
of these patients have been the subject of previous 
reports by Ebert, Turley, and their associates, s' 11, 12 
who described operative results, early outcomes will 
not be discussed in the present report. 
Patients and methods 
Patients. The study group for the present report con- 
sisted of 165 patients who underwent complete repair of 
truncus arteriosus at the University of California, San 
Francisco, between 1975 and 1995 and who survived the 
early postoperative p riod and had records available for 
review. Early survivors were defined as patients who were 
discharged from the hospital and who survived at least 30 
days from the time of repair, and early events were 
defined as events that occurred uring the same hospi- 
talization or within 30 days of operation. Medical 
records could not be located for three known early 
survivors, and these patients were not included in the 
165-patient cohort. The median age at operation was 
3.5 months (range 2 days to 36 years), and 81% of 
patients (n = 133) were less than i year of age (infants). 
The median weight of patients was 4.3 kg at the time of 
the operation and ranged from 2.2 to 52 kg. Seventeen 
patients (10%) were referred to our institution after 
having undergone one or more previous procedures, 
including pulmonary artery banding (n = 15), repair of 
interrupted aortic arch (n = 2; performed with pulmo- 
nary artery banding, n = 1), systemic-pulmonary tery 
shunt (n = 4; after pulmonary artery banding, n = 3), 
and pacemaker placement (n = 1). Truncus types, 
according to the Van Praagh classification system, 1 
were type A1 or A2 (n = 153), type A3 (n = 6), and type 
A4 (with interrupted aortic arch; n = 6). Associated 
cardiovascular nomalies are listed in Table I. Data on 
coronary artery abnormalities, truncal malalignment, 
truncal valve leaflet structure, and truncal valve stenosis 
were believed tO be inadequate and were not included 
in the analysis. 
Operative procedures. Complete repair of truncus ar- 
teriosus was performed with the use of cardiopulmonary 
bypass in all patients. Median total perfusion time was 76 
minutes (range 41 to 433 minutes) but varied considerably 
among surgeons. Aortic crossclamp times ranged from 0 
to 212 minutes (median 30 minutes), with a technique of 
only partial aortic crossclamping performed in three pa- 
tients. Total circulatory arrest was used in six patients and 
ranged in duration from 4 to 55 minutes. The VSD was 
closed with a patch through aright infundibulotomy. After 
excision of the pulmonary artery trunk or branch pulmo- 
nary arteries from the aorta, patients underwent recon- 
struction of the right ventricular outflow tract with a 
porcine valve housed in a synthetic tube (n = 125), a 
cryopreserved aortic (n = 27) or pulmonary (n = 12) 
valved allograft conduit, or direct anastomosis ofthe right 
ventricle to the main pulmonary artery (n = 1). Between 
1975 and 1985, all patients except for three (one in 1981 
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Table  II .  Early events in hospital survivors of 
complete truncus repair 
No. of 
Postoperative event variable patients* 
Reoperation 40 
For bleeding 38 
Right ventricle-pulmonary tery conduit 1 
revision 
Permanent pacemaker placement 1 
Cardiopulmonary arrest (one or more) 14 
Pulmonary hypertensive crisis 10 
Seizures (one or more, clinically evident) 8 
Complete heart block 1 
Ventilator dependence in days; median 4 (1 to 63) 
(range) 
Postoperative hospital stay in days; median 
(range) 
15 (7 to 90) 
*Values indicate number of patients in whom each event/variable oc-
curred; in no case did a single category ofevent take place more than once 
in a single patient. 
and two in 1982) received synthetic onduits with porcine 
valves. In 1986, both xenograft and allograft valved con- 
duits were used. Since 1987, allograft valved conduits have 
been used exclusively, with mainly aortic allografts used 
until 1991 and pulmonary allografts used preferentially 
since 1992. The aortic root defect was usually closed 
primarily, but a glutaraldehyde-treated p ricardial patch 
or a Dacron patch was used to repair large or irregular 
defects. Ten patients with moderate or severe preopera- 
tive truncal valve regurgitation underwent truncal valvu- 
loplasty or annuloplasty (n = 5), truncal valve replace- 
ment with a mechanical valve (n = 2), or truncal root 
replacement with a cryopreserved allograft aortic root 
(n = 3). Additional procedures performed at the time of 
truncus repair included repair of interrupted aortic arch 
(n = 4), closure of a patent foramen ovale or secundum 
atrial septal defect (n = 16), pulmonary arterioplasty (n - 
4), reduction of a dilated truncal root (n = 1), mitral valve 
cleft closure (n = 1), coronary artery ostium repair (n = 
1), and right ventricular outflow tract muscle resection 
(,, = 1).  
Data eellection and statistical analysis. Preoperative 
and perioperative data were collected on retrospective 
review of patient records. Follow-up was carried out by 
means of physician or patient contact and was completed 
by February 1996. SPSS for Windows version 6.01 (SPSS 
Inc., Chicago, Ill.) was used to perform statistical calcula- 
tions. Data are expressed as median and either range or 
95% confidence intervals (CI). The Kaplan-Meier product 
limit method and Cox proportional hazards regression 
methods were used for actuarial survival analysis and 
analysis of freedom from reoperation (all reoperations, 
conduit reoperations, and truncal valve reoperations). 
Multiple regression analysis was performed as conditional 
backward stepwise proportional hazards regression. Pa- 
tients lost to follow-up were censored from survival and 
Tab le  I I I .  Causes of late death (n = 23) in hospital 
survivors of complete truncus repair 
Duration Age at 
after epair repair 
Cause of death (mo) (mo) 
Arrhythmia 
Pneumonia 
RSV infection, sepsis, respiratory arrest 
Acute LV failure after truncal valve re- 
placement for severe truncal valve insuf- 
ficiency* 
CP arrest, as a result of bacterial endocar- 
ditis (possible conduit malfunction) 
Could not be weaned from CPB during 
third residual VSD repair* 
CP arrest after repair of residual VSD, 
with pneumonia and sepsis* 
Sudden respiratory distress and CP arrest 
Global cerebral damage and sepsis after 
truncal valve replacement* 
Sudden respiratory distress and CP arrest 
Truncal valve prosthesis became lodged 
open, massive truncal valve insutficiency 
Sudden respiratory distress and CP arrest 
CP arrest after conduit reoperation* 
Could not be weaned from CPB during 
conduit reoperation* 
Subarachnoid hemorrhage, one day after 
conduit reoperation* 
CP arrest (obscure proximal cause; 2.5 
weeks after jellyfish sting) 
Irreversible PVOD (not transplant candi- 
date) 
Hepatic failure caused by DPH toxicity (af- 
ter grand mal seizure) 
CP arrest after second truncal valve re- 
placement and residual VSD closure* 
Could not be weaned from CPB during 
second reoperation (conduit reoperation) 
Renal failure after myocardial infarction 
Pulmonary edema, rule out Pneumocystis 
pneumonia 
CP arrest during reoperation for bleeding 
after third reoperation (conduit reopera- 
tion)* 
2 1.9 
2 3.2 
2 1.9 
2 1.9 
3 13.2 
4 1.6 
4 1.5 
6 2.9 
7 4.2 
8 0.1 
8 0.2 
11 7.6 
11 2.8 
34 1.9 
46 1.3 
52 0.9 
60 77 
66 3 
78 35 
105 2.7 
117 432 
117 8 
139 1.6 
*Reoperation related. RSV,, Respiratory s ncytial virus; LV,, left ventricu- 
lar; CP, cardiopulmonary; CPB, cardiopulmonary bypass; VSD, ventricular 
septai defect; PVOD, pulmonary vascular obstructive disease; DPIt, di- 
phenhydramine. 
freedom from reoperation analyses at the time they were 
lost to follow-up. Independent variables analyzed are 
listed in the appendix. 
Results 
Ear ly reoperat ions,  compl icat ions,  and hospital  
outcomes  among study group pat ients  are summa-  
r ized in Tab le  II. 
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Fig. 1. Actuarial survival among hospital survivors of complete truncus repair. Survival curves are shown 
for all patients and for infants (patients under 1 year of age at repair). 
Table IV. Factors found to be significantly associated with decreased survival by univariate and multiple 
proportional hazards regression analysis 
Univariate analysis Multiple regression analysis 
Hazard ratio Hazard ratio 
Variable (95% CI) p Value (95% CI) p Value 
Age <3 mo 0.59 0.02 0.86 0.59 
(0.38-0.92) (0.10-1.48) 
Aortic crossclamp time 0.92 0.02 0.92 0.03 
(continuous) (0.86-0.99) (0.85-0.99) 
Postoperative hospital stay 1.03 0.006 1.01 0.26 
(continuous) (1.01-1.05) (0.99-1.04) 
Interrupted aortic arch 2.85 0.007 5.43 0.004 
(1.33-6.11) (1.71-17.25) 
Moderate or severe prerepair 1.75 0.02 1.84 0.04 
truncal valve regurgitation (1.09-2.82) (1.02-3.34) 
Follow-up and survival. Patients were followed 
up for a median of 10.5 years (range 0.1 to 20.4 
years). Twenty-five patients were lost at cross-sec- 
tional follow-up, but a median of 1.1 years of 
follow-up (range 1 month to 12 years, total 67 
patient-years) was available on these patients. 
Twenty-three patients died during the follow-up 
period; causes of death are listed in Table III. 
Thirteen of the 23 late deaths (57%) occurred 
within 1 year of truncus repair. Ten patients died 
early after reoperations for conduit replacement 
(n = 5), isolated truncal valve replacement (n = 2), 
isolated residual VSD closure (n = 2), or a second 
truncal valve replacement with residual VSD closure 
(n = 1). Eleven late deaths occurred before any 
reoperation. Actuarial survival was 90% at 5 years, 
85% at 10 years, and 83% at 15 and 20 years after 
repair (Fig. 1). Among infants, actuarial survival was 
almost identical, with 90% at 5 years, 87% at 10 
years, and 83% at 15 years (Fig. 1). Factors signifi- 
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Fig. 2. Actuarial freedom from reoperation after r pair of truncus arteriosus. 
cantly associated with decreased survival by univar- 
iate and multivariate analysis are listed in Table IV. 
Eight of the 23 late deaths occurred in patients with 
moderate or severe prerepair truncal insufficiency, 
including five of the 13 patients who died within 1 
year of repair. Three of the patients with interrupted 
arch died during the follow-up period, all within 16 
months of the operation. All surviving patients were 
in New York Heart Association class I at follow-up, 
except for three patients with decreased exercise 
tolerance, who were in class II. 
Reoperations. During the follow-up period, 119 
patients underwent a total of 164 reoperations. 
Many of these were performed at other institutions. 
The median time to reoperation after initial truncus 
repair was 5.1 years (95% CI, 4.7 to 5.5 years; Fig. 
2). Factors significantly associated with shorter du- 
ration to reoperation were the same as those for 
conduit reoperation (discussed later). Ten patients 
died early after reoperation, for a reoperation mor- 
tality rate of 6.1% (10/164). None of the factors 
analyzed was significantly associated with death 
after reoperation, and there have been no reopera- 
tion-related eaths ince 1989. 
Conduit reoperations. At the time of cross-sec- 
tional follow-up, 107 patients had undergone a total 
of 133 conduit reoperations (replacement or revi- 
sion). Twenty patients had undergone multiple con- 
duit reoperations, including five patients in whom 
three or four conduit replacements had been per- 
formed. Five patients died at the time of conduit 
reoperation for an overall mortality of 3.8% (5/133) 
related to conduit replacement. The median right 
ventricle-pulmonary artery gradient at the time of 
first conduit replacement was 61 mm Hg (range 15 
to 156 mm Hg). Median time to conduit reoperation 
was 5.5 years (95% CI, 4.9 to 6.1 years). By 
univariate proportional hazards regression analy- 
sis, age less than 3 months (hazard ratio = 1.45 
[95% CI, 1.19 to 1.79]; p = 0.0003), smaller 
conduit size (hazard ratio for conduit size as a 
continuous variable = 0.82 [95% CI, 0.73 to 0.91]; 
p = 0.0001), and lower weight at the time of 
complete truncus repair (hazard ratio for weight 
as a continuous variable = 0.93 [95% CI, 0.87 to 
0.99]; p = 0.02) were significantly associated with 
shorter duration to conduit reoperation. On mul- 
tivariate analysis, weight fell out of the equation, 
leaving age less than 3 months (hazard ratio = 
0.79 [95% CI, 0.63 to 0.98];p = 0.03) and smaller 
conduit size (hazard ratio for conduit size as a 
continuous variable = 0.87 [95% CI, 0.77 to 1.03]; 
p = 0.009) as independent risk factors for shorter 
duration to conduit reoperation. Fig. 3 depicts the 
difference in freedom from conduit reoperation be- 
tween patients less than and greater than 3 months of 
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Fig. 3. Actuarial freedom from conduit reoperation (replacement or revision) in patients less than and 
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freedom from conduit reoperation i patients under 3 months at repair was 55 months (95% CI, 45 to 65 
months). 
age at initial truncus repair. There was no significant 
difference in time to conduit replacement when 
comparing patients who received synthetic versus 
allograft conduits (p = 0.90). 
Truncal valve reoperations. During the follow-up 
period, 26 patients underwent a total of 30 truncal 
valve replacements (four patients had two replace- 
ments each). Truncal valve replacement ( he initial 
replacement in those who had two truncal valve 
replacements) was performed as a first reparative 
procedure without conduit replacement in six pa- 
tients, as a first reoperation along with conduit 
reoperation i  16 patients, as a second reoperation 
along with a second conduit replacement in two 
patients, as a third procedure in one patient, and as 
a fourth procedure along with a fourth conduit 
reoperation in one patient. Replacement valves 
were mechanical in 26 patients and aortic root 
allografts in four patients. In one patient, a Konno 
left ventricular outflow tract enlargement was per- 
formed at the time of a second truncal valve replace- 
ment. Three patients died early after a reoperation 
that involved truncal valve replacement, including 
two patients who died alter isolated truncal valve 
replacement as a first reoperation and one patient 
who died after a second truncal valve replacement. 
Another patient died 2 months after uneventful 
truncal valve replacement, after the mechanical 
replacement valve became lodged in the open posi- 
tion, leading to massive truncal insufficiency and 
left-sided failure. Overall freedom from truncal 
valve replacement was 95% at 2 years, 91% at 5 
years, 84% at 10 years, and 68% at 15 years after 
truncus repair (Fig. 4). The only independent risk 
factor for earlier truncal valve replacement was 
prerepair truncal valve insufficiency (p < 0.0001; 
Fig. 4). 
Other reoperations. Branch pulmonary arterio- 
plasty was performed at the time of conduit reop- 
eration in 18 patients and before conduit reopera- 
tion in 14 patients (four surgical, 10 percutaneous). 
A residual VSD was closed in 19 patients: before 
any other reoperation in three patients (two of 
whom required second and third procedures to close 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 113, Number 5 
Rajasinghe t al. 8 7 5 
100 
90 
80 
70 
~. 6O 
50 
40 
E 
30 
;~ 20 
10 
~wm 
~mml|~ 
q m.  
' tm| |mm | .  
d in |  m 
Xenografl 
. . . .  Allografi 
4.  
umlmlmm.  
i i 3' z~ 5' 6 ~ 8 ; 1'0 ;1 1'2 1'3 14 
At Risk: Time (years) 
Xenografi 126 106 99 93 78 64 43 36 29 15 10 9 5 2 1 
Allograft 39 29 22 18 13 10 7 5 3 2 1 1 
Fig. 4. Actuarial freedom from conduit reoperation according to the type of right ventricle-pulmonary 
artery conduit used at initial truncus repair. 
recurrent residual VSDs), and with conduit (n = 15) 
or truncal valve (n = 1) reoperation i 16 patients. 
Residual atrial septal defect closure was performed 
along with conduit replacement in five patients. One 
patient underwent repair of cor triatriatum, mitral 
valve cleft, and a defect in the ascending aorta 
resulting from conduit erosion, all at the time of a 
second conduit reoperation. One patient underwent 
placement of a permanent sequential trioventricu- 
lar pacemaker after the development of a hemody- 
namically unstable second-degree h art block after 
conduit reoperation. 
Discussion 
The impetus that stimulated early surgical correc- 
tion of truncus arteriosus was recognition that as 
children were allowed to grow older they became 
unsuitable surgical candidates because of the devel- 
opment of progressive pulmonary vascular obstruc- 
tive disease',. Early reports of truncus repair from the 
Mayo Clinic experience showed a correlation be- 
tween increasing early mortality and higher levels of 
pulmonary vascular esistance. 3 Ebert and associ- 
ates 5showed that early surgical correction of trun- 
cus arteriosus in infancy could be undertaken safely 
with low morbidity and mortality. More recent re- 
ports by Hanley, 7Bove, 6 and their associates dem- 
onstrated that elective repair in the neonatal period 
was not only feasible but preferable. In current 
surgical practice, early primary repair of truncus 
arteriosus i the standard approach to treatment of 
this lesion. To date, however, little information is 
available on the long-term results of such a policy. 
This report specifically examined the long-term 
survival of a large group of patients who underwent 
early truncus arteriosus repair at a single institution. 
Although a number of the patients included in the 
present cohort were neonates, most were not, and 
thus our study group is not entirely representative of 
most patients undergoing truncus repair in the 
current era. A total of 165 long-term survivors 
undergoing repair at a median age of 3.5 months 
were followed up for up to 20 years. Late survival 
rates were 90%, 85%, and 83% at 5, 10, and 15 
years, respectively, with the overwhelming majority 
of these patients in excellent health. Of the 23 late 
deaths in our experience, the majority (57%, 13/23) 
occurred within the first year after discharge from 
the hospital after truncus repair: Five were related 
to residual defects at reoperation; three were the 
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result of sudden cardiopulmonary arrests; three 
were of an infectious origin; and one death each 
resulted from a mechanical valve dysfunction and 
rhythm disturbance. These results compare favor- 
ably with previously published long-term survival 
studies.9, 10 
Of 30 independent variables analyzed for associ- 
ation with long-term outcomes, prerepair truncal 
valve insufficiency of moderate or greater degree, 
interrupted aortic arch, and shorter crossclamp time 
were found to correlate significantly with poorer 
survival by multivariate Cox regression analysis. 
Patients with preoperative truncal insufficiency or 
interrupted aortic arch (or both) accounted for 10 of 
the 23 late deaths and half of the deaths occurring 
within i year of repair. The association of shorter 
crossclamp time with poorer time-related survival 
was likely an artifact, because this variable was 
confounded by the great variation in cardiopulmo- 
nary bypass and aortic crossclamp times between 
surgeons and across the study period. In addition, 
inasmuch as very few patients with interrupted 
aortic arch were included in this cohort, it is doubt- 
ful that any conclusions can be drawn regarding the 
association between interrupted arch and long-term 
prognosis. Among the 23 late deaths in this experi- 
ence, only one was attributable to the development 
of irreversible pulmonary vascular obstructive dis- 
ease. This occurred in a patient who underwent 
truncus repair at the age of 6.4 years and died 5 
years after the operation, at which time the patient 
was not deemed a transplant candidate. This is in 
sharp contrast o the early Mayo Clinic experience, 
in which more than 40% (9/21) of late deaths were 
associated with the presence of pulmonary vascular 
obstructive disease and in which progression of 
pulmonary vascular obstructive disease was found to 
increase the risk of late death, l° This difference in 
late mortality is likely explained by the significant 
difference in the distribution of ages at which pa- 
tients underwent runcus repair between the two 
studies (3.5 months vs 6 years). These results dem- 
onstrate for the first time that adoption of a policy of 
early truncus repair to avoid the early morbidity and 
hospital mortality associated with progressive pul- 
monary vascular obstructive disease appears to have 
a favorable influence on long-term survival as well. 
A significant proportion of late deaths (10/23) 
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occurred at reoperation for conduit replacement, 
truncal valve replacement, or residual VSD closure. 
The overall mortality from conduit replacement was 
3.8%. Although it was difficult to assess risk factors 
for poor outcome after late reintervention, owing in 
large part to the fact that many of the reoperations 
were performed at other institutions, there were no 
significant predictors of reoperation-related mortal- 
ity. Nevertheless, there have been no deaths related 
to reintervention since 1989. 
A large majority of the patients in this experience, 
particularly those operated on during the years 1975 
to 1985, received xenograft valved synthetic on- 
duits. After 1987, valved allografts were exclusively 
used for repair. However, there was no significant 
difference in time to conduit replacement between 
synthetic onduits and allografts when patients were 
viewed in aggregate. Only younger age and smaller 
conduit size were independent risk factors for 
shorter time to conduit reoperation, reflecting the 
largely younger age of patients undergoing repair. 
Numerous tudies, including an age-matched com- 
parison we have reported previously, have shown 
improved durability of truncus arteriosus repair 
with cryopreserved allograft valves. 13' 14 However, 
direct comparisons with our own overall experi- 
ence may be difficult to make because of many 
uncontrolled variables, most important, the issue 
of specific hemodynamic indications for conduit 
replacement. Nevertheless, valved homografts 
may offer superior performance and are generally 
believed to be more appropriate for neonatal 
repair, particularly when considering technical 
issues related to sternal closure and anastomosis of
the conduit to thin friable pulmonary arteries. 
Whether a synthetic or allograft conduit is used for 
early truncus repair, though, we may surmise from 
our experience that the need for late conduit rein- 
tervention is almost inevitable. 
Although the natural history of truncal insuffi- 
ciency after primary truncus repair is not widely 
known, truncal valve insufficiency remained a signif- 
icant source of long-term morbidity in our follow- 
up. In our experience, concomitant truncal valve 
replacement or repair at the time of initial truncus 
repair was done only in the most severe forms of 
truncal valve regurgitation. Any degree of prerepair 
truncal valve regurgitation (mild, moderate, or se- 
vere) was found to be a significant predictor of 
subsequent truncal valve replacement. The absence 
of any preoperatively detectable truncal valve in- 
sufficiency made the likelihood of truncal valve 
replacement extremely low, but not zero. Fur- 
thermore, moderate to severe truncal valve regurgi- 
tation was an independent risk factor for poorer 
long-term survival. 
In conclusion, 10- to 20-year survival and func- 
tional status are excellent among infants undergoing 
complete repair of truncus arteriosus. Predictably, 
conduit replacement or revision is almost invariably 
necessary. Patients with truncal insufficiency who do 
not undergo truncal valve repair or replacement at 
initial truncus repair are at significantly higher risk 
for late truncal valve replacement and should be 
monitored closely for evidence of increasing truncal 
valve dysfunction, especially in the early postopera- 
tive period. 
REFERENCES 
1. Van Praagh R, Van Praagh S. The anatomy of common 
aorticopulmonary trunk (truncus arteriosus communis) 
and its embryologic implications. Am J Cardiol 1965;16: 
406-25. 
2. Calder L, Van Praagh R, Van Praagh S, et al. Truncus 
arteriosus communis. Clinical, angiographic, and pathologic 
findings in 100 patients. Am Heart J 1976;92:23-38. 
3. Marcelletti C, McGoon DC, Mair D. The natural history of 
truncus arteriosus. Circulation 1976;54:108-11. 
4. McGoon DC, Rastelli GC, Ongley PA. An operation for the 
correction of truncus arteriosus. JAMA 1968;205:69-73. 
5. Ebert PA, Turley K, Stanger P, Hoffman JIE, Heymann MA, 
Rudolph AM. Surgical treatment of truncus arteriosus in the 
first 6 months of life. Ann Surg 1984;200:451-6. 
6. Bove E, Beekman R, Snider, et al. Repair of truncus 
arteriosus in the neonate and young infant. Ann Thorac Surg 
1989;47:499-506. 
7. Hanley FL, Heinemann MK, Jonas RA, et al. Repair of 
truncus arteriosus in the neonate. J Thorac Cardiovasc Surg 
1993;t05:1047-56. 
8. Lacour-Gayet F, Serraf A, Komiya T, et al. Truncus arterio- 
sus repair: influence of techniques of right ventricular out- 
flo~v tract repair. J Thorac Cardiovasc Surg 1996;111:849-56. 
9. Marcelletti C, McGoon DC, Danielson GK, Wallace RB, 
Mair DD. Early and late results of surgical repair of truncus 
arteriosus. Circulation 1977;55:636-41. 
10. Di Donato RM, Fyfe DA, Puga FJ, et al. Fifteen-year 
experience with surgical repair of truncus arteriosus. J Tho- 
rac Cardiovasc Surg 1985;89:414-22. 
11. Boyce SW, Turley K, Yee ES, Verrier ED, Ebert PA. The 
fate of the 12 mm porcine valved conduit from the right 
ventricle to the pulmonary artery. J Thorac Cardiovasc Surg 
1988;95:201-7. 
12. Turley K, Turley K, Ebert PA. Aortic allografts: reconstruc- 
tion of right ventricle-pulmonary artery continuity. Ann 
Thorac Surg 1989;47:278-81. 
13. Schaff HV, DiDonato RM, Danielson GK, et al. Reoperation 
for obstructed pulmonary ventricle-pulmonary artery con- 
duits: early and late results. J Thorac Cardiovasc Surg 
1984;88:334-43. 
14. Reddy VM, Rajasinghe HA, McElhinney DB, Hanley FL. 
878 Rajasinghe t aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
May 1997 
Performance of right ventricle to pulmonary artery conduits 
after repair of truncus arteriosus: a comparison of Dacron- 
housed porcine valves and cryopreserved allografts. Sem 
Thorac Cardiovasc Surg 1995;7:133-8. 
Discussion 
Dr. Gordon K. Danielson (Rochester, Minn.). The au- 
thors are to be congratulated for their comprehensive 
analysis and superb results. The treatment of truncus 
arteriosus has come a long way since the first successful 
repair by Dr. Dwight McGoon at the Mayo Clinic in 
September 1967. An irradiated aortic homograft was used 
to establish right ventricle-pulmonary artery continuity. 
The philosophy in those early years of repair was to delay 
operation in infants for as long as possible to allow them 
to grow older so that they would "tolerate the procedure 
better." As a result, infants were being sent for operation 
when they were either in intractable cardiac failure or had 
pulmonary vascular obstructive disease, and the results 
were far from ideal. Dr. Ebert and associates at the 
authors' institution pioneered early surgical repair for 
truncus and showed that the risks for repair in infancy 
were actually less than for older patients. For many years, 
at each update of their series, the operative risk for repair 
in patients under the age of 6 months was about half the 
risk for repair between 6 and 12 months. Dr. Hanley's 
group has nicely shown that late survival is also improved 
by early repair, particularly by abolishing the attrition that 
occurs when patients already have pulmonary vascular 
obstructive disease at the time of repair. Pulmonary 
vascular obstructive disease, and the progression thereof, 
in our early series of patients accounted for 40% of the 
late deaths. 
There are many interesting aspects of this report that 
could be discussed. Time constraints limit my comments 
to two late complications that are yet to be resolved. The 
first is the problem of late conduit stenosis. It is of interest 
that the authors have found no significant difference in 
time to conduit replacement between porcine-valved Da- 
cron conduits and cryopreserved homografts. This is 
similar to our finding that cryopreserved aortic ho- 
mografts are no better than previous conduits. 
[Slide] Survivorship free from conduit failure for cryo- 
preserved aortic homografts in our experience is shown in 
the orange line, directly overlying the line for irradiated 
aortic homografts, which had the worst outcome of all the 
Conduits we have used. It is interesting that porcine-valved 
Dacron conduits actually had better freedom from con- 
duit failure. The pulmonary homografts tended not to 
calcify as rapidly as aortic homografts. However, if one 
includes anastomotic aneurysms and the development of
valvular insufficiency in the definition of conduit failure, 
the survivorship for pulmonary homografts looks similar 
to that for aortic homografts. It is reassuring, however, 
that the risk for conduit change alone, as the authors have 
indicated, is small and has little adverse effect on late 
patient survival. 
The second consideration is late development of aortic 
or truncal valve insufficiency. Even though truncal insuf- 
ficiency may be absent or only mild after repair, it may 
progress relentlessly, requiring operation for correction. 
The same phenomenon is seen after repair of pulmonary 
atresia, but to a lesser extent. It is interesting that in both 
conditions, the aorta is dilated from carrying all of the 
pulmonary and systemic blood flow, and this may be a 
mechanism for development of aortic valve insufficiency. 
I notice that the aortic valve was replaced in all of the 
reoperations for aortic insufficiency in the authors' report. 
With newer techniques of aortic valve repair, do the 
authors believe satisfactory epair of the truncal valve will 
also be possible? Have they considered performing an 
annuloplasty if only mild or moderate truncal valve insuf- 
ficiency is present, perhaps at the time of conduit change, 
and do they think this might help delay or prevent late 
reoperation for severe aortic valve insufficiency? 
Dr. Rajasinghe. Thank you very much, Dr. Danielson. 
With regard to conduit reoperations and late conduit 
stenosis, I completely agree with you. In our experience, 
as in yours, the fact that there was no significant difference 
in time to conduit replacement based on conduit type 
reflects a number of factors, many of which could not be 
controlled. One is specific hemodynamic ndications for 
the conduit replacement: his may be quite variable 
depending on the surgeon. Furthermore, there was a 
significant difference in age distribution between the 
groups of study in your paper, as well as in our experience. 
Our patients tended to be younger and were under 6 
months of age predominantly, and they were several years 
older in the Mayo Clinic experience. I do believe, though, 
that all of these conduits eventually will have to be 
replaced, and that can be undertaken with very low 
mortality. 
With regard to the truncal valve and very mild degrees 
of insufficiency, I do not have a uniform policy to apply at 
the time of truncus repair; however, I do believe that it is 
important o carefully inspect and address the truncal 
valve, because ven mild regurgitation can progress over 
time and require subsequent valve replacement. The 
anatomy of the truncal valve can be quite variable. The 
valve has anywhere from two to six leaflets and can be 
extremely dysmorphic. In those instances in which the 
valve is extremely dysmorphic, it may well prove worth- 
while to perform an annuloplasty for mild insufficiency at 
the time of complete truncus repair. I believe this will help 
delay the development of late aortic insufficiency. Ulti- 
mately, the decision to perform an annuloplasty will be an 
operative one, and the judgment of the surgeon will be of 
critical importance. Our data support your observation 
that the presence of preoperative truncal valve insuffi- 
ciency is a significant risk factor for subsequent valve 
replacement. 
Dr. Miguel Barbero Marcial (Sg~o Paulo, Brazil). At the 
Heart Institute of Silo Paulo, since 1987, we have been 
following a different policy for correction of truncus, that 
is, we are not using an extracardiac conduit in truncus type 
1 or 11/2. In a total series of 45 patients, we have an early 
mortality of 12 patients, 26%; and two unrelated late 
deaths. Reoperation to relieve pulmonary stenosis was 
necessary in only two of the 31 long-term survivors. To 
decrease the immediate mortality of 26%, since 1993 we 
have been doing this operation only in neonates and 
infants less than 5 months of age. To avoid massive 
pulmonary regurgitation during hypertensive crises in the 
postoperative period, we are placing the new commer- 
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cially available monocusp in the high position of the new 
outflow tract of the right ventricle. Among the 12 patients 
operated on in this recent period, we have only one 
immediate death. 
I would like to ask Dr. Rajasinghe if he considered 
coronary anomalies, mainly the ostium stenosis, as a 
risk factor for the immediate or late postoperative 
course. 
Dr. Rajasinghe. Thank you. We did not specifically 
examine coronary artery anomalies in our experience as 
an independent risk factor, in large measure because the 
data from our medical records were believed to be 
inadequate with poor documentation attimes. However, a 
number of previously published studies, including a series 
from Boston Children's Hospital several years ago by Dr. 
Hanley, showed that coronary artery anomalies were a 
risk for early mortality and reduced intermediate-term 
survival as well. I think this information should be closely 
kept and monitored in addition to the presence of an 
interrupted aortic arch and the presence of truncal valve 
insufficiency. 
Appendix 
Independent variables analyzed by Cox proportional 
hazards regression analysis for correlation with late events 
after complete repair of truncus arteriosus: 
Demographic variables 
Year of operation 
Age at operation 
Continuous 
Less than 3 months (yes/no) 
Weight at operation 
Previous palliative procedure (yes/no) 
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Morphologic variables 
Truncus type other than Van Praagh AI or A2 (yes/no) 
Truncal valve insufficiency 
Mild or greater (yes/no) 
Moderate or greater (yes/no) 
Atrial septal defect or patent foramen ovale (yes/no) 
Interrupted aortic arch (yes/no) 
Right aortic arch (yes/no) 
DiGeorge syndrome (yes/no) 
Hypoplastic or stenotic branch pulmonary arteries 
(yes/no) 
Other cardiac anomalies (yes/no) 
Operative variables 
Cardiopulmonary bypass time 
Aortic crossclamp time 
Circulatory arrest (yes/no) 
Conduit type (synthetic/allograft) 
Conduit size (diameter) 
Continuous 
Less than 12 mm (yes/no) 
Truncal valve replacement or repair (yes/no) 
Interrupted aortic arch repair (yes/no) 
Additional surgical procedure (yes/no) 
Early postoperative variables 
Reoperation 
All cardiac (yes/no) 
For bleeding (yes/no) 
Pulmonary hypertensive crisis (yes/no) 
Complete heart block (yes/no) 
Cardiopulmonary arrest (yes/no) 
Seizures (yes/no) 
Ventilator dependence (days) 
Postoperative hospital stay (days) 
